[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Daiichi Sankyo Company Limited

Daiichi Sankyo's Enhertu faces pricing and market access hurdles despite positive oncology pipeline news. Social media buzz highlights potential tariffs impacting Japanese-made drugs, adding to market sentiment concerns.

### About Daiichi Sankyo Company Limited
Daiichi Sankyo Company Limited is a global pharmaceutical company focused on oncology.  

### Insights
- Daiichi Sankyo Company Limited sentiment is up XXXXX% from the previous month.
- Daiichi Sankyo Company Limited mentions is up XXXXX% from the previous week.

### Price: $
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/close.tsv)  
Daiichi Sankyo stock fell XXX% due to an unchanged profit target and pricing/market access challenges, despite positive oncology pipeline news. Social posts also mention potential tariffs impacting Japanese-made drugs, which could further influence market sentiment.  

1-Year High: $XXXXX on 2025-01-22  
1-Year Low: $XXXXX on 2025-04-17  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/alt_rank.tsv)  
Daiichi Sankyo Company Limited is currently AltRank #917 based on combined combined social and market metrics
Daily Average: XXX  
1-Year High: XXXXX on 2025-03-10  
1-Year Low: XXX on 2025-01-21  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
1-Year High: XX on 2025-02-25  
1-Year Low: XX on 2025-07-21  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXXX -XX%  
1-Year High: XXXXXXXXX on 2025-03-31  
1-Year Low: XX on 2025-01-09  

Engagements by network (24h):
Reddit: XX
TikTok: XX
X: XXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX +15%  
X Month: XXX -XX%  
X Months: XXX -XXXX%  
X Year: XXXXX +109%  
1-Year High: XX on 2025-07-18  
1-Year Low: X on 2024-12-16  

Mentions by network (24h):
Reddit: XX
TikTok: X
X: XX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX no change  
X Month: XX -XX%  
X Months: XXX -XXXX%  
X Year: XXX +116%  
1-Year High: XX on 2025-07-04  
1-Year Low: X on 2024-12-16  

The most influential creators that mention Daiichi Sankyo Company Limited in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@DaiichiSankyoUS](/creator/twitter/DaiichiSankyoUS) | X    | XXXXX     | X     | XXX         |
| [@H2AK119ub](/creator/reddit/H2AK119ub)              | X    | XXXXXX    | X     | XX          |
| [@tom_the_bomb__](/creator/twitter/tom_the_bomb__)   | X    | XXXXX     | X     | XX          |
| [@biotechtv](/creator/tiktok/biotechtv)              | X    | XXXXX     | X     | X           |

[View More](/list/creators/$4568t/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +17%  
X Month: XXX% +33%  
X Months: XXX% +20%  
X Year: XXX% no change  
1-Year High: XXX% on 2024-12-11  
1-Year Low: XX% on 2025-02-01  

Most Supportive Themes:
- Oncology Pipeline Advancement: (40%) Daiichi Sankyo is making significant strides in its oncology pipeline, particularly with its antibody-drug conjugate (ADC) technology, leading to promising trial results and regulatory advancements.
- Strategic Partnerships and Collaborations: (30%) The company is actively engaging in strategic partnerships, notably with AstraZeneca, to co-develop and commercialize innovative cancer treatments, enhancing its market position and R&D capabilities.
- Market Expansion and Product Launches: (20%) Daiichi Sankyo is focused on expanding its market reach through new product launches and label expansions, as seen with Enhertu, indicating a strong commercial strategy and growing product portfolio.
  
Most Critical Themes:
- Pricing and Market Access Challenges: (70%) Despite promising trial data, Daiichi Sankyo faces challenges related to pricing and market access for its key drugs, as highlighted by the NICE decision regarding Enhertu, which could impact adoption rates.
- Competition in the Oncology Space: (30%) The oncology market is highly competitive, with numerous companies vying for market share. Daiichi Sankyo's success depends on maintaining its innovative edge and effectively differentiating its treatments.
  
  
  
### Market Cap: $undefined
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$4568t/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$4568t/time-series/market_cap.tsv)  
Current Value: $undefined  
Daily Average: $XXXXXXXXXXXXXXXXX  
1-Year High: $XXXXXXXXXXXXXXXXX on 2025-01-22  
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-20  

### Top Daiichi Sankyo Company Limited Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"#BREAKINGNEWS: We initiated the DESTINY-Ovarian01 phase X trial evaluating our HER2 directed ADC as a combination first-line maintenance therapy in patients with HER2 expressing advanced high-grade epithelial ovarian cancer"  
[X Link](https://x.com/DaiichiSankyoUS/status/1998370568211706251) [@DaiichiSankyoUS](/creator/x/DaiichiSankyoUS) 2025-12-09T12:34Z 4438 followers, XXX engagements


"Have you registered for our upcoming webinar Were covering: ✔ HR+ HER2-low & HER2-ultralow mBC updates ✔ The evolving role of T-DXd ✔ DESTINY-Breast06 key findings Join us Dec XX at 1pm ET. Register: Sponsored by AstraZeneca & Daiichi Sankyo"  
[X Link](https://x.com/FLPathologists/status/1998150719480770710) [@FLPathologists](/creator/x/FLPathologists) 2025-12-08T22:00Z 1931 followers, XX engagements


"Daiichi Sankyo presents data from five breast cancer trials at SABCS: DESTINY-Breast11 DESTINY-Breast05 DESTINY-Breast09 DESTINY-Breast03 featuring ENHERTU and TROPION-Breast02 with DATROWAY showing overall survival improvement in triple negative breast cancer"  
[X Link](https://x.com/lasyavavilala15/status/1998146884196618502) [@lasyavavilala15](/creator/x/lasyavavilala15) 2025-12-08T21:45Z X followers, XX engagements


"Benefits of Joining the DIA Membership by Terry Katz"  
[YouTube Link](https://youtube.com/watch?v=QmaE4N6gBT4) [@druginfoassoc](/creator/youtube/druginfoassoc) 2025-12-08T20:02Z 3080 followers, XX engagements